VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
46,870MODERNA
532GLAXOSMITHKLINE BIOLOGICALS
353PFIZER\BIONTECH
231MERCK & CO. INC.
221UNKNOWN MANUFACTURER
62SEQIRUS, INC.
25DYNAVAX TECHNOLOGIES CORPORATION
13EMERGENT BIOSOLUTIONS
12SANOFI PASTEUR
9NOVARTIS VACCINES AND DIAGNOSTICS
5PFIZER\WYETH
5PAXVAX
2TEVA PHARMACEUTICALS
2PROTEIN SCIENCES CORPORATION
1BERNA BIOTECH, LTD.
1INTERCELL AG
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL1,906
1,575
289
IMM209286
252
236
229
s029456178
171
UT7065MA166
155
149
145
S034636133
107
U62828AA103
100
98
P10025327596
U6737AA85
UJ446AA79
78
78
59
57
4BH3254
4F47253
52
27656352
50
PP9L548
49TM346
42
40
38
MENVEO38
4F47237
R1B252M36
34
C5763AA30
93362229
25
300057A24
UNK24
22
CW311621
18
17
15
UH894AB15
3Y7NL12
R1B743M12
EJ168611
el128410
10
10
10
9
ARBA141A9
UNK9
8
UNK8
8
1F4EB8
Unknown7
7
No batch number6
5
5
UJ090AA5
5
5
4
4
4
UNK4
JEV18K95E4
UNK3
A115A3
Z127A3
3
3333324181073
2
2
2
TAR352
1
1
1
1
1
A739081
1
1
1
1
1
037K20A68,542
EL128447,700
133

Incidents per State

State Total
15,185
CA14,096
NY7,507
TX7,196
FL6,939
IN5,527
PA4,560
IL4,179
OH4,054
AZ3,856
MI3,771
NJ3,411
MA3,278
VA3,208
NC3,114
WA3,034
GA2,864
MD2,652
MN2,534
CO2,532
WI2,457
MO2,029
OR1,943
TN1,715
CT1,693
KY1,603
OK1,226
AL1,201
KS1,162
IA1,157
SC1,106
NM1,065
UT973
AR951
LA945
NE829
NV797
ME795
MT789
NH756
ID674
AK661
WV661
PR650
MS585
HI536
RI510
VT441
SD361
ND356
DE350
DC239
WY209
GU32
AS16
VI13
MP9
MH3
FM2
QM1
XB1

ID: 0962172
Sex: F
Age:
State: MN

Vax Date: 01/15/2021
Onset Date: 01/16/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies: Seasonal pollens

Symptoms: I have swelling under my arm (lymph node) after receiving second dose of the Shingrix vaccine.

Other Meds: Maxzide, atenolol, celexa, amitriptyline, levothyroxine, Wellbutrin, Restasis, Vit D, magnesium, Zyrtec, ibuprofen, Tylenol, nexium, famotidine, simethicone

Current Illness:

ID: 0962174
Sex: F
Age:
State: DE

Vax Date: 01/09/2021
Onset Date: 01/09/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Headache; Tired; Diarrhea; Sore nipples; Sore injection site; This is a spontaneous report from a contactable healthcare professional (patient). A 49-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number and expiration date were not reported), intramuscularly on the left arm on 09Jan2021 (08:15) at a single dose for COVID-19 immunization at the hospital. The patient had no relevant medical history. The patient's concomitant medications were not reported. On 09Jan2021, the patient had headache; was tired; had diarrhea; sore nipples; and sore injection site. The patient did not receive any treatment for the reported events. The outcome of the events, 'headache', 'tired', 'diarrhea', 'sore nipples' and 'sore injection site', was recovering. The patient was not diagnosed with COVID-19 prior to vaccination, and was not tested post-vaccination. Information about lot and batch number was requested.

Other Meds:

Current Illness:

ID: 0962175
Sex: F
Age:
State: WA

Vax Date: 01/11/2021
Onset Date: 01/12/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Body aches; chills; headache; fatigue; This is a spontaneous report from a contactable nurse (patient). A 50-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3248), via an unspecified route of administration at right arm on 11Jan2021 at 10:45 at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL0140), via an unspecified route of administration at left arm on 23Dec2020 at 17:30 at single dose for COVID-19 immunization. On 12Jan2021 at 02:00, the patient experienced body aches, chills, headache and fatigue. The patient outcome of the events was recovering.

Other Meds:

Current Illness:

ID: 0962176
Sex: M
Age:
State: FL

Vax Date:
Onset Date:
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Clear liquid that leaked from the site of injection; some bleeding from the site; This is a spontaneous report from a contactable nurse. A male patient of an unspecified age received bnt162b2 (BNT162B2, Manufacturer Pfizer -BioNTech), via an unspecified route of administration, on an unspecified date, at single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient noticed some bleeding from the site as well as clear liquid that leaked from the site of injection. Outcome was unknown. The information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0962177
Sex: F
Age:
State: FL

Vax Date: 01/11/2021
Onset Date: 01/11/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Slight tenderness at injection site; This is a spontaneous report from a contactable consumer (patient) and a contactable other health professional. A 67-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration at arm left on 11Jan2021 at 11:15 for COVID-19 immunization. The patient medical history included known allergies to adhesive from an unknown date and unknown if ongoing. The patient concomitant medication included metronidazole (METROGEL), vitamin c, cholecalciferol (VITAMIN D), krill oil (MEGARED OMEGA 3 KRILL OIL), cyanocobalamin (B12). On an unspecified date, the patient previously took triple antibiotic ointment and experienced allergy. The patient experienced slight tenderness at injection site on 11Jan2021 at 17:00. The patient outcome of the event was recovering. The information on the batch number has been requested.

Other Meds: METROGEL; VITAMIN C [ASCORBIC ACID]; VITAMIN D [COLECALCIFEROL]; MEGARED OMEGA 3 KRILL OIL; B12 [CYANOCOBALAMIN]

Current Illness:

ID: 0962178
Sex: F
Age:
State: LA

Vax Date: 01/12/2021
Onset Date: 01/12/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: tightness of shoulders and neck; tightness of shoulders and neck; started having severe nausea in the last hour; Has a slight headache; This is a spontaneous report from a contactable consumer (patient herself). A 70-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 12Jan2021 08:00 in left arm at single dose for covid-19 immunization. Medical history included ongoing diabetes (she had it for 20 years), ongoing asthma (she had it for 25 years), ongoing cirrhosis of the liver non alcoholi diagnosed two years ago, ongoing hypertension diagnosed in the last three months, ongoing fatty liver diagnosed two years ago. There were no concomitant medications. Patient had Covid vaccine this morning at 8 am (12Jan2021) that was fine after 15 minutes, but patient started having severe nausea in the last hour and was unresolved by her nausea medicine. Patient had a slight headache. Patient stated that the headache which was mild, tightness of shoulders and neck started at 13:30. Patient stated that she took acetaminophen 1000 units and used a heating pad for the shoulder. Outcome of nausea was not recovered, and outcome of events were recovered on 12Jan2021. Information on the lot/batch number has been requested.

Other Meds:

Current Illness: Asthma (she had it for 25 years); Cirrhosis of liver (diagnosed two years ago); Diabetes (she had it for 20 years); Fatty liver (diagnosed two years ago); Hypertension (diagnosed in the last three months)

ID: 0962179
Sex: M
Age:
State: AL

Vax Date: 01/05/2021
Onset Date:
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Date: 20201106; Test Name: Covid-19; Test Result: Positive

Allergies:

Symptoms: bleeding from the penis; This is a spontaneous report from a contactable Nurse. A 78-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), lot EL0142, via an unspecified route of administration in left arm on 05Jan2021 at single dose for covid-19 immunisation. Medical history included fracture displacement on 23Dec2020, atrial fibrillation, non-hodgkin's lymphoma, post surgical ortho care, semen bleeding, from an unknown date and unknown if ongoing, Covid positive on 06Nov2020 (he was Covid positive before and didn't want to get it again and give it to his wife). There were no concomitant medications. The patient underwent lab tests and procedures which included Covid test positive on 06Nov2020. The patient experienced bleeding from the penis on an unspecified date with outcome of unknown. Nurse wanted to know if there is information about interactions between blood thinners and the vaccine.; Sender's Comments: Based on temporal association, the causal relationship between BNT162B2 and the event penile haemorrhage cannot be excluded. The information available in this report is limited and does not allow a medically meaningful assessment. Of note, semen bleeding was reported as medical history and no concomitant medications were reported; hence, the role of other possible medical conditions or medications cannot be ruled out. This case will be reassessed once additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 0962180
Sex: M
Age:
State: MD

Vax Date:
Onset Date: 12/30/2020
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Patient received casirivimab instead of intended COVID vaccine. At follow up Jan 4, patient reported having shortness of breath and fast heart rate (has pacemaker). Will see provider this week. Not yet scheduled to receive COVID 19 vaccine

Other Meds: casirivimab

Current Illness:

ID: 0962181
Sex: M
Age:
State: CA

Vax Date: 12/23/2020
Onset Date: 12/01/2020
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Date: 202101; Test Name: blood work; Result Unstructured Data: Test Result:Fine; Comments: blood work; Test Date: 20201230; Test Name: covid; Test Result: Positive ; Test Date: 202101; Test Name: X-ray; Result Unstructured Data: Test Result:Fine

Allergies:

Symptoms: rash; developed symptoms of covid on 27Dec / on 30Dec2020 he tested positive for the virus / cough; developed symptoms of covid on 27Dec / on 30Dec2020 he tested positive for the virus / cough; This is a spontaneous report from a contactable consumer (patient). A 63-year-old male patient received the 1st does of bnt162b2 (BNT162B2) at single dose left upper arm on 23Dec2020 for Covid-19 immunisation, administered at hospital. Medical history included ongoing hypertension that began maybe 10 years before and still ongoing, controlled with medication. No family medical history relevant to the events. The concomitant medications included paracetamol (TYLENOL). History of all previous immunization with the Pfizer vaccine considered as suspect was none. No additional vaccines administered on same date of the suspect. The patient had not received any other vaccines within 4 weeks prior to the BNT162B2 vaccine. He has not had reactions to any other vaccines. On 30Dec2020 he tested positive for Covid. His symptoms of covid started 27Dec2020 in the evening sometime probably around 7pm. He experienced cough in Dec2020. No visit to physician office was required. On the 06Jan2021 he went to the emergency room but that was because he was concerned about rash he developed. He thought it was due to the Tylenol he was taking. Relevant tests performed in Ja2021 included: blood work and chest X-ray did when he went in for the rash and they were was fine. He was treated with steroid injection for the rash. The rash cleared up in the next couple days. As of 12Jan2021 the only thing he has cough but he coughs anyway. He still had a cough but it was not atypical for him to have a cough. He was scheduled to receive his second dose on 13Jan2021. He no longer had any Covid symptoms and wanted to know if he could still get the second dose as scheduled. The outcome of event tested positive for the virus and not recovered was unknown, of coughs was not recovered. A Product Complaint was filed. Information on lot/batch number has been requested.

Other Meds: TYLENOL

Current Illness: Hypertension (began maybe 10 years before, still ongoing, controlled with medication)

ID: 0962182
Sex: M
Age:
State: TN

Vax Date: 01/07/2021
Onset Date: 01/07/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Date: 20201120; Test Name: COVID; Result Unstructured Data: Test Result:negative

Allergies:

Symptoms: nausea; vomiting; Mild headache; arm was hurting/Left arm soreness; This is a spontaneous report from a contactable physician reporting for himself. A 47-years-old male patient received the second dose of bnt162b2 (BNT162B2; Lot # EJ1686) vaccine , intramuscular in the left deltoid on 07Jan2021 11:00 at single dose for Covid-19 immunisation . The patient medical history was not reported. There were no concomitant medications. Previously on 17Dec2020 the patient received the first dose of BNT162B2 vaccine. The patient experienced nausea and vomiting on 10Jan2021 23:59 with outcome of recovered , mild headache on 07Jan2021 20:30 with outcome of recovered , arm was hurting/left arm soreness on 07Jan2021 20:30 with outcome of recovered. The patient underwent lab tests and procedures which included sars-cov-2 antibody test: negative on 20Nov2020. Nausea and vomiting were considered Important Medical Events.; Sender's Comments: Based on temporal association, the causal relationship between bnt162b2 and the events nausea and vomiting cannot be excluded. The information available in this report is limited and does not allow a medically meaningful assessment. This case will be reassessed once additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 0962183
Sex: F
Age:
State: OK

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Date: 20210108; Test Name: Fever; Result Unstructured Data: Test Result:100- 101 Fahrenheit; Comments: fever ranged between 100- 101 oral; Test Date: 20201021; Test Name: Covid-19; Result Unstructured Data: Test Result:Covid-19; Comments: I had been diagnosed with Covid-19 21Ocober with symptoms onset on 15Oct2020. These symptoms were much like when I had Covid, but very self limiting and lasted not even 48hrs really

Allergies:

Symptoms: chills; fatigue; deep muscle aching in both arms; fever ranged between 100-101 F; This is a spontaneous report from a contactable nurse (patient). A 60-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EK9231), via an unspecified route of administration at left arm on 08Jan2021 at 09:30 at single dose for COVID-19 immunization. The patient medical history included seasonal allergy from an unknown date and unknown if ongoing and COVID-19 from Oct2020 (as reported: "I had been diagnosed with COVID-19 on 21Oct2020 with symptoms onset on 15Oct2020") to an unknown date. The patient's concomitant medication included cetirizine hydrochloride (ZYRTEC ALLERGY), aspirin, calcium/cholecalciferol (CALCIUM + D3), docusate. The patient previously took COMPAZINE and BACTRIM DS and experienced allergies. The patient reported that on 08Jan2021 at 21:00 developed chills, fatigue, deep muscle aching in both arms and fever ranged between 100- 101 F. On 09Jan2021 at 09:00 he felt fine, until approximately 17:00 and again developed chills, muscle aching and fatigue. On 10Jan2021 at 08:30 all symptoms were gone and never returned. The patient underwent lab tests and procedures which included SARS-COV-2 test: positive on 21Oct2020. The patient outcome of the events was recovered on 10Jan2021 at 08:30.

Other Meds: ZYRTEC ALLERGY; ASPIRIN [ACETYLSALICYLIC ACID]; CALCIUM + D3 [CALCIUM;COLECALCIFEROL];

Current Illness:

ID: 0962184
Sex: F
Age:
State: CA

Vax Date: 01/11/2021
Onset Date: 01/12/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Really bad headache; Really itchy/itching in her upper body and in legs, like a rash; Rash/itching in her upper body and in legs, like a rash; Mottled skin; This is a spontaneous report from a contactable nurse reporting for herself A 41-years-old female patient received bnt162b2 (BNT162B2; Lot #EL3249) vaccine , in the left arm on 11Jan2021 13:00 at single dose for Covid-19 immunisation . The patient medical history was not reported. There were no concomitant medications. The patient experienced really bad headache on 12Jan2021 with outcome of unknown , really itchy/itching in her upper body and in legs, like a rash on 12Jan2021 with outcome of unknown , mottled skin on 12Jan2021 with outcome of unknown. Unknown treatment was given for really bad headache The reported events were considered Important Medical Events.; Sender's Comments: Based on temporal association, the causal relationship between bnt162b2 and the events headache, pruritus, rash and livedo reticularis cannot be excluded. The information available in this report is limited and does not allow a medically meaningful assessment. This case will be reassessed once additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 0962185
Sex: F
Age:
State: FL

Vax Date:
Onset Date:
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: fever; chills; shaking; This is a spontaneous report from a contactable consumer. This consumer reported similar events for 17 patients. This is the second of seventeen reports. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date: unknown), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. Medical history included covid-19. The patient's concomitant medications were not reported. Consumer reported that multiple friends had the "regular side effects" of soreness in the arm but another one of her friends, which was the patient, also had COVID prior to getting the vaccine and had a similar reaction to the reporter of fever, chills and shaking on an unspecified date. Outcome of the events was unknown. Reporter asked if having COVID prior to getting vaccinated could cause worsen symptoms Information on the lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021018227 same reporter/ drug/ events, different patient

Other Meds:

Current Illness:

ID: 0962186
Sex: F
Age:
State:

Vax Date: 12/22/2020
Onset Date:
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Name: covid-19 infection; Test Result: Positive

Allergies:

Symptoms: tested positive after 1st dose; tested positive after 1st dose; This is a spontaneous report from a contactable Nurse. This nurse reported similar events for 2 patients. This is the second of two reports. This Nurse reported for a 65-year-old female patient (Mother) received 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 22Dec2020 at single dose for covid-19 immunization. There was no medical history and no concomitant medications. Mother received 1st dose on 22Dec2020, tested positive for covid-19 infection after 1st dose. Outcome of the event was unknown. Information on the lot/batch number has been requested.; Sender's Comments: Based on available information, a possible contributory role of the subject product, BNT162B2 vaccine, cannot be excluded for the reported events of Covid-19 virus test positive and suspected LOE due to temporal relationship. There is limited information provided in this report. Additional information is needed to better assess the case, including complete medical history, diagnostics, counteractive treatment measures and concomitant medications. This case will be reassessed once additional information is available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate,Linked Report(s) : US-PFIZER INC-2021015122 same reporter/drug/AE, different patient.

Other Meds:

Current Illness:

ID: 0962187
Sex: F
Age:
State: MD

Vax Date: 01/09/2021
Onset Date: 01/09/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Fatigue; Nausea; Vomiting; Myalgia; Headache; Dose Number: 1 on 12Dec2020, Dose Number: 2 on 09Jan2021; This is a spontaneous report from a non-contactable other HCP. A 35-years-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 09Jan2021 at single dose on left arm for covid-19 immunisation. Medical history included none. No COVID prior vaccination. The patient's concomitant medications were not reported. The patient previously received first dose of BNT162B2 on 12Dec2020 02:00 PM on right arm and experienced fatigue and a headache for 2 days. The patient experienced fatigue, nausea, vomiting, myalgia, headache on 09Jan2021. No treatment received for the events. Outcome of events was recovering. No COVID tested post vaccination. No follow-up attempts are possible. Information on Lot/Batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 0962188
Sex: M
Age:
State: NC

Vax Date: 01/16/2021
Onset Date: 01/17/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data: Temperature Measurement, 17-Jan-2021. 101.1; My normal daily temperature varies (am) from 96-8 to 97.5

Allergies: Mild food allergies resulting in inconsequential hives

Symptoms: I received a Shingrix (Zoster) 50 mcg vaccination the afternoon of 2021-01-16. The usual sore arm was expected, however, I also developed a +4 deg fever with 24 hours. The elevated temperature began to subside about 10 hours after onset.

Other Meds: None; Multi-vitamin, aspirin, flax seed meal

Current Illness: None

ID: 0962189
Sex: F
Age:
State: MO

Vax Date: 01/12/2021
Onset Date: 01/12/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Loss of consciousness; Muscle aches; Headache; Nausea; Vomiting; Dose1 26Dec2020, dose 2 12Jan2021; Dose1 26Dec2020, dose 2 12Jan2021; This is a spontaneous report from a contactable nurse. A 25-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular on the right arm second dose on 12Jan2021 12:15 at a single dose (lot number: EK4176) and intramuscular on the right arm first dose on 26Dec2020 10:15 at a single dose (lot number: EL1284) for COVID-19 immunisation. Medical history included asthma. Concomitant medication included Women's multivitamin within two weeks of vaccination. The patient had no allergies to medications, food, or other products; was not diagnosed with COVID-19 prior to vaccination, did not receive any other vaccines within four weeks prior to the COVID vaccine and was not pregnant at the time of vaccination. The most recent COVID-19 vaccine was administered at a hospital facility. On 13Jan2021 03:30, the patient experienced muscle aches, headache, nausea, vomiting and loss of consciousness. Treatment was not received for the events. Since the vaccination, the patient has not been tested for COVID-19. Outcome of the events was recovering. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0962190
Sex: F
Age:
State: KY

Vax Date: 01/07/2021
Onset Date: 01/07/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Date: 20210111; Test Name: covid test post vaccination (Antigen and PCR); Result Unstructured Data: Test Result:SARS-CoV-2 test negative; Test Date: 20210111; Test Name: covid test post vaccination (Antigen and PCR); Result Unstructured Data: Test Result:SARS-CoV-2 test negative; Test Date: 20210111; Test Name: covid test post vaccination (Nasal Swab); Result Unstructured Data: Test Result:SARS-CoV-2 test negative

Allergies:

Symptoms: Headache; extreme fatigue; all over body aches; stomach pain; diarrhea; unable to move R arm due pain and swelling; unable to move R arm due pain and swelling; unable to move R arm due pain and swelling; This is a spontaneous report from a contactable healthcare professional (patient). A 58-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number EK-9231 and expiration date not reported), intramuscular on the right arm, on 07Jan2021 at 07:15 at a single dose for Covid-19 immunization. Medical history included fibromyalgia and chronic fatigue syndrome. The patient has no known allergies to medications, food or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient is not pregnant at the time of vaccination. Concomitant medications included vitamin D, niacin, hydrocodone bitartrate, paracetamol (NORCO), and paracetamol (TYLENOL). On 07Jan2021 at 11:00AM, the patient experienced headache, extreme fatigue, all over body aches, stomach pain, diarrhea, and unable to move R arm due pain and swelling. The patient did not receive treatment for the adverse events. The patient underwent Covid test post vaccination (Antigen and PCR) and result was SARS-CoV-2 test negative on 11Jan2021. The outcome of the events was recovered/resolved in Jan2021. The reporter assessed the events as non-serious.

Other Meds: VITAMIN D [VITAMIN D NOS]; NIACIN; NORCO; TYLENOL

Current Illness:

ID: 0962191
Sex: F
Age:
State: MD

Vax Date: 12/23/2020
Onset Date: 12/23/2020
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: left arm started tingling; roof of my mouth started tingling then my tongue started tingling and felt like it was getting a little larger; heart palpitations; lower half of my face went numb; Right eye also felt weird like vibrating; This is a spontaneous report from a contactable nurse. A 27-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1685), via an unspecified route of administration in left arm on 23Dec2020 15:30 at single dose for COVID-19 immunization. Medical history included COVID-19 from an unknown date and unknown if ongoing prior to vaccination of BNT162B2. Concomitant medication included ibuprofen (ADVIL), ibuprofen and escitalopram oxalate (LEXAPRO). The patient stated, "my left arm started tingling and it was very strong by my finger tips" on 23Dec2020 03:45 PM. The patient stated, "then the roof of my mouth started tingling then my tongue started tingling and felt like it was getting a little larger. Then I got heart palpitations. The mouth tingling went away in ten minutes but then 15 minutes later the lower half of my face went numb and that lasted about 10 minutes. Right eye also felt weird like vibrating" on 23Dec2020. No treatment received for the adverse events. The facility where the most recent COVID-19 vaccine was administered was in the hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The events were considered non serious as it did not result in death, were not life threatening, did not cause/prolonged hospitalization, were not disabling/Incapacitating and had no congenital anomaly/birth defect. The outcome of the events was recovered on unspecified date.

Other Meds: ADVIL [IBUPROFEN]; ; LEXAPRO

Current Illness:

ID: 0962192
Sex: M
Age:
State: OH

Vax Date:
Onset Date:
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: The patient that contracted COVID, 19 days after the first dose; The patient that contracted COVID, 19 days after the first dose; This is a spontaneous report from a Pfizer-sponsored program from a contactable physician reporter for himself. A male patient of an unspecified age received the first dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, batch/lot number and expiration date unknown), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient that contracted COVID 19 days after the first dose and want to know what guidance offer for that situation. The outcome of the event was unknown. Information on lot/batch number has been requested.; Sender's Comments: Based on available information, a possible contributory role of the subject product, BNT162B2 vaccine, cannot be excluded for the reported events of Covid-19 and suspected LOE due to temporal relationship. There is limited information provided in this report. Additional information is needed to better assess the case, including complete medical history, diagnostics, counteractive treatment measures and concomitant medications. This case will be reassessed once additional information is available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 0962193
Sex: M
Age:
State:

Vax Date: 01/07/2021
Onset Date: 01/12/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: a little nauseous; chills; headache; feeling like he is getting the flu; body aches; This is a spontaneous report from a non-contactable consumer (Patient wife). A 78 years old male patient received first dose of BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 07Jan2021 at unspecified age at single dose for COVID-19 vaccination. The patient medical history and concomitant medications were not reported. The patient began with side effects last night on 12Jan2021. He was feeling a little nauseous, chills, headache. The patient was feeling like he was getting the flu. She didn't think he was running a fever and didn't feel like he was burning up or anything, just body aches. The caller wonder whether the side effects related to the vaccine or should he get tested, since the side effects were 5 days after the first dose and she didn't see any timeline for these reactions. The outcome of the events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 0962194
Sex: F
Age:
State: WY

Vax Date: 01/18/2021
Onset Date: 01/18/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Patient had an allergic reaction.

Other Meds:

Current Illness:

ID: 0962195
Sex: M
Age:
State: TX

Vax Date: 01/01/2021
Onset Date: 01/01/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Name: blood pressure; Result Unstructured Data: Test Result:High

Allergies:

Symptoms: bad dreams; tightness around my head like there was a band around my head/Pressure like a band was around his head; was going to the bathroom a lot and had a lot of loose stools/digestive track issues with 6 loose stools; felt shaky all day long; woke up feeling lousy/Woke up early and did not feel good; Shivering; This is a spontaneous report from a contactable other HCP (patient). A male patient of an unspecified age (Age: 75) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot #EJ1685 (or possibly S instead of a 5)) on unknown date in Jan2021 at single dose for COVID-19 immunisation. Medical history included he did have high blood pressure most of the time and it is under control with medications. The patient's concomitant medications were not reported. He received the first one on Saturday where he is a volunteer worker. He received it at noon on last Saturday and did not have any effects he could tell. They watched him for a while and dismissed after half an hour and was the fine rest of that day. He was fine on Sunday and Monday, but on Tuesday, he woke up early at 4am and just did not feel good. He was having a bad dream, could not get back to sleep. He had a tightness around his head like there was a band around his head. His head felt pressure like a band was around his head. It was not really a headache. He does have high blood pressure most of the time and it is under control with medications. However, yesterday, along with the pressure in his head, he also had digestive track issues which he described as 6 loose stools in the day. He was going to the bathroom a lot and had a lot of loose stools. He was not running fever and it was colder in the night and day but he was dressed appropriately. He felt shaky all day long. He was shivering all day long, but had no fever. He woke up feeling lousy. He went to bed early and slept really well and was better. He would like to know if this sounds like a delayed reaction. The outcome was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0962196
Sex: F
Age:
State:

Vax Date: 01/13/2021
Onset Date:
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: headache; This is a spontaneous report from a non-contactable consumer (patient). A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 13Jan2021 at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received her first dose this afternoon on 13Jan2021, but has developed a headache, the patient wanted to know if she can take some ibuprofen. The outcome of the event was unknown. No follow up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 0962197
Sex: M
Age:
State: AZ

Vax Date: 12/31/2020
Onset Date: 01/01/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: allergy; I have had additional swelling around my upper body including my right eye and right upper quadrant, right ribs.; I have had additional swelling around my upper body including my right eye and right upper quadrant, right ribs.; I have had additional swelling around my upper body including my right eye and right upper quadrant, right ribs.; my Tongue started swelling; both hands started swelling; Foot swelling including the ankle; Foot swelling including the ankle; This is a spontaneous report from a contactable other hcp reported for himself. A 56-year-old male patient receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: bh9899), intramuscular on 31Dec2020 13:30 in left arm at single dose (first dose) for COVID-19 immunization. There were no concomitant medications and medical history. After a day of the vaccine which was giving on Thursday 31Dec2020, patient started experiencing sided effects of his foot swelling including the ankle. On Sunday (03Jan2021), both hands started swelling, Monday (04Jan2021) morning his tongue started swelling and went to his doctor. He administered a steroid and prescribed an Epinephrine pen just in case it got worse and was also prescribed additional medicines for his allergy. Since he had had additional swelling around his upper body including his right eye and right upper quadrant, right ribs. AE treatment including steroid injection, hydroxyzine HCL 25 mg, Methylprednisolone 4 mg. AE resulted in doctor or other healthcare professional office/clinic visit. No other vaccine in four weeks and no other medications in two weeks. There was no COVID tested post vaccination and COVID prior vaccination. The outcomes of events were resolved with sequel.; Sender's Comments: Based on the time association, the possible contribution of suspect BNT162B2 to the events cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 0962198
Sex: F
Age:
State: NY

Vax Date: 12/21/2020
Onset Date: 12/01/2020
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Hives; I used the Pfizer vaccine and had allergic reaction; This is a spontaneous report from a contactable nurse (patient). A 31-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EK5730; expiry date: 21Dec2020) via an unspecified route of administration, on 21Dec2020, at a single dose, for COVID-19 immunization. The patient has no relevant medical history and has no concomitant medications. The patient stated that she received the Pfizer vaccine and she had an allergic reaction on an unspecified date in Dec2020. She was told by infectious disease to report it. She also reported that she got hives 3 days later. The patient did not receive treatment for the events. Outcome of the events was unknown. The patient and the physician (whom she consulted) both considered a causal relationship between the events and the suspect drug.

Other Meds:

Current Illness:

ID: 0962199
Sex: U
Age:
State:

Vax Date: 01/01/2021
Onset Date: 01/01/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Sore arm; fatigue; This is a spontaneous report from a contactable pharmacist (patient). A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced sore arm and fatigue in Jan2021 lasting 24 hours with outcome of recovered. No follow-up attempts are possible. Information about Lot or Batch Number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 0962200
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: three weeks of intense fatigue; This is a spontaneous report from a contactable Other-HCP (patient) via Pfizer sales representative. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE Solution for injection, lot no. and expiry date not reported), via an unspecified route of administration on an unspecified date at a single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. Patient reported three weeks of intense fatigue following first dose of Pfizer COVID vaccine administration. Outcome of the event fatigue was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0962201
Sex: M
Age:
State:

Vax Date: 01/09/2021
Onset Date: 01/01/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: achy/sore; clammy; This is a spontaneous report from non-contactable physician (patient) via Pfizer Sales Representative. This male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 09Jan2021 at single dose for covid-19 immunisation. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) for covid-19 immunisation. The patient felt achy, clammy and sore in Jan2021. Outcome of the events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 0962202
Sex: F
Age:
State:

Vax Date: 01/11/2021
Onset Date: 01/11/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: throat tightness; chills; fever; This is a spontaneous report from a contactable pharmacist (patient) via Pfizer sales representative. A female patient of an unspecified age received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date not reported), via an unspecified route of administration on 11Jan2021 at a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously took first dose of bnt162b2 (lot number and expiry date not reported) on an unspecified date at single dose for COVID-19 immunisation. Within 5-10 minutes, she noted throat tightness which she successfully treated with diphenhydramine. Within 1-2 hours she noted chills and fever which partially resolved with ibuprofen. Clinical outcome of throat tightness was unknown while for the other events was recovering. Information on the lot/ batch number has been requested.

Other Meds:

Current Illness:

ID: 0962203
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: now she has a cold; This is a spontaneous report from a contactable nurse, reporting for herself. A female patient of an unspecified age received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date were not reported), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162B2, via an unspecified route of administration on 21Dec2020 at a single dose for COVID-19 immunization and experienced head cold, nose running, stuffy and sneezing. It was reported that the patient got the second dose of vaccine and was fine and now she has a cold on an unspecified date. The outcome of the event was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0962204
Sex: F
Age:
State: WI

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: shortness of breath (SOB) with hyperventilation; shortness of breath (SOB) with hyperventilation; Lightheaded; red blotching on face and neck; appeared shaky; This is a spontaneous report from a contactable pharmacist. An adult female patient (pregnant unknown) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 08Jan2021 for first dose at single dose (lot number: EL1283) for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced lightheaded, shortness of breath (SOB) with hyperventilation on 08Jan2021. She was laying on the floor and appeared shaky with red blotching on face and neck on 08Jan2021. Medical response called. Anaphylaxis medication given epinephrine (adult) IM outer thigh. Patient was placed on stretcher and taken to emergency room (ER). Patient also received Diphenhydramine and Famotidine. The events resulted in emergency room/department or urgent care. It was unknown if covid prior vaccination and if covid tested post vaccination. The outcome of the events was recovered in Jan2021.; Sender's Comments: Based on the compatible time association, the possible contribution of suspect BNT162b2 to the events cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 0962205
Sex: F
Age:
State: NJ

Vax Date: 12/20/2020
Onset Date: 12/20/2020
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: soreness in her left arm; headache; tired; This is a spontaneous report received from a contactable consumer (patient). A 57-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EZ0140, expiry date: unknown), intramuscular in upper left arm, on 20Dec2020 at 14:45-15:00 (as reported), at single dose, for preventive/COVID-19 immunization, in an education center that was turned into a hub for vaccine. Medical history included thyroid, cholesterol and blood pressure. Concomitant medications include medications (unspecified) for thyroid, cholesterol and blood pressure. The patient did not receive prior vaccinations within 4 weeks. The patient experienced a little headache and was tired on 20Dec2020. The patient took Advil and on 21Dec2020, her headache was gone, and she was tired. On 22Dec2020, the second day after receiving the first dose, she recovered completely. It was also reported that the patient experienced soreness in her left arm on an unspecified date. The patient recovered from headache on 21Dec2020 and from fatigue on 22Dec2020. The outcome of vaccination site pain was unknown.

Other Meds:

Current Illness:

ID: 0962206
Sex: F
Age:
State: MA

Vax Date: 01/09/2021
Onset Date: 01/10/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: She woke up thinking she didn't sleep; Nausea; sore arm; was really tired; This is a spontaneous report from a contactable consumer (patient). A 52-year-old female received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EK9231), via an unspecified route of administration at the right arm on 09Jan2021 at single dose for COVID-19 immunization. The patient had no medical history and there were no concomitant medications. The patient took the first dose of the Covid-19 vaccine and was fine. The lot for the first dose of the vaccine was EH9899. She received it on 19Dec2020 (at the age of 51 years). She took the second dose on Saturday (09Jan2021). She experienced nausea and had a sore arm on 10Jan2021. It was not death defying. She was also really tired on 10Jan2021. She was advised by her employer to report this information. She took some Tylenol and relaxed. She was no longer nauseated or tired. Her arm was not sore only tender. She woke up thinking she didn't sleep on an unspecified date. The patient added that her boss said she might have to be tested. The patient asked if that was something that she needs to do. The outcome of the events nausea and tired was recovered on 11Jan2021. The outcome of the event sore arm was recovering. And the outcome of the event "She woke up thinking she didn't sleep" was unknown.

Other Meds:

Current Illness:

ID: 0962207
Sex: M
Age:
State: IL

Vax Date: 12/21/2020
Onset Date: 01/01/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Sore throat; Congestion; Dry cough; Feeling unwell; Upper resp infection; This is a spontaneous report from a contactable healthcare professional (patient) via a Pfizer. A male patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date: unknown), via an unspecified route of administration from 21Dec2020 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. but the agent is unsure what type. Patient received his first dose of the COVID 19 vaccine in Dec2020. The second dose is due tomorrow with the expected 21 day interval. He felt congestion and a stuffy nose with sore throat and a dry cough and was feeling unwell 10Jan2021. Patient thought he has a upper resp infection on an unspecified date in Jan2021. He didn't have fever or chills. Outcome of the events was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0962208
Sex: F
Age:
State:

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Difficult to breathe; Sore throat; Congestion; super congested and found it difficult to breathe; She was cold; Tingling in her fingers; This is a spontaneous report from a contactable physician (patient). A female patient of an unspecified age received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number and Expiration Date were not reported), via an unspecified route of administration, on 08Jan2021 at 15:00, at a single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient got the second dose of the vaccine on Friday (08Jan2021) at 3:00 PM and an hour or two later, she was cold and had tingling in her fingers. Everything got better. On Saturday (09Jan2021), the patient had sore throat and congestion. On Sunday (10Jan2021), the patient was super congested and found it difficult to breathe. That could have been because of congestion. Today (11Jan2021), the patient was still congested. The patient is not sure if that is a vaccine side effect or if she should get tested for coronavirus. The main thing is the congestion. All the other has resolved. The patient worked in the hospital and was not sure if she should get tested. The patient had not recovered from "Congestion; super congested and found it difficult to breathe". The patient recovered from the other events in Jan2021. Information about lot number and expiration date for the suspect product will be requested in follow-up attempts.

Other Meds:

Current Illness:

ID: 0962209
Sex: F
Age:
State: CA

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: sensitivity to cold; feeling chilled; short of breath (SOB) with minimal exertion; This is spontaneous report from a non-contactable nurse reported for herself. A 61-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date unknown) intramuscular in the left arm on 08Jan2021 12:00 at single dose for Covid-19 immunization in a hospital. Medical history included COPD, hypothyroidism and allergies to penicillin (PCN). The patient was not pregnant. The patient has no COVID prior vaccination. Concomitant medications included fluticasone furoate, umeclidinium bromide, vilanterol trifenatate (TRELEGY), montelukast sodium (SINGULAIR), oxybutynin, and azelastine; all from unspecified date for unspecified indication. The patient previously took Celebrex and experienced allergies. Historical vaccine included first dose of BNT162B2 intramuscular in the left arm on 20Dec2020 09:15 (61 years old) at single dose for Covid-19 immunization in a hospital. The patient has no other vaccine in four weeks. On 08Jan2021 15:45, the patient experienced sensitivity to cold, or feeling chilled for 48 hours post dose, short of breath (SOB) with minimal exertion for 72 hours post dose. The events resulted in doctor or other healthcare professional office/clinic visit. The patient was not COVID tested post vaccination. The patient did not received treatment due to the events. The outcome of the events sensitivity to cold, or feeling chilled, short of breath (SOB) with minimal exertion was not recovered. No follow-up attempts are possible, information about batch number cannot be obtained.

Other Meds: TRELEGY; SINGULAIR; ;

Current Illness:

ID: 0962210
Sex: F
Age:
State: NH

Vax Date: 01/07/2021
Onset Date: 01/07/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Name: fever; Result Unstructured Data: Test Result:low grade

Allergies:

Symptoms: red flushed on one side of her face; both sides of her face were very red, hot, and blotchy; both sides of her face were very red, hot, and blotchy; both sides of her face were very red, hot, and blotchy; She feels like her skin is burning; right side of face started feeling numb and tingling; right side of face started feeling numb and tingling; Chills; low grade fever; Fatigue; back and body aches; normal body aches/back and body aches; Nausea; This is a spontaneous report from a contactable consumer. A 37-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; lot number: EL3246), via an unspecified route of administration on 07Jan2021 at single dose for COVID-19 immunization. The patient's medical history was not reported. There were no concomitant medications. The first vaccine BNT162B2 she received on 18Dec2020. She didn't have any side effects to it. It's lot number was EH9899. Caller just wanted to report her adverse reaction to the COVID 19 vaccine. She got it for work. She got her second vaccine on Thursday. The first vaccine was fine. That Friday she was sick. On 07Jan2021, the patient experienced low grade fever, fatigue, back and body aches, nausea. On 08Jan2021, the patient experienced chills, and normal body aches. On 10Jan2021, the patient experienced right side of face started feeling numb and tingling. This started around her jaw line at 8 o'clock. Then it worked up her face. It was only on the right side. She then monitored it. She went to bed. She woke up at 4 am, and she felt like her face was on fire on an unspecified date. It was tingly. Her face was bright red and blotchy on both sides of her face. She took Benadryl, and put cold compresses on her face. This morning, both sides of her face were very red, hot, and blotchy. She feels like her skin is burning. She feels like she had a burn on her face.It is very odd. There were a couple of days between her reaction and when it started. It has worsened. This morning for work she couldn't put her video on. The outcome of the event low grade fever, back aches, nausea, was recovered on 08Jan2021, fatigue, normal body aches/body aches, chills was recovered on 09Jan2021, the outcome of the events right side of face started feeling numb and tingling was not recovered, while unknown for the other events. Treatment was received for the events "Her face was bright red and blotchy on both sides of her face.", She feels like her skin is burning.

Other Meds:

Current Illness:

ID: 0962211
Sex: F
Age:
State: CA

Vax Date: 01/10/2021
Onset Date: 01/10/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Sore arm; swollen/tender lymph nodes in armpit of injection arm; swollen/tender lymph nodes in armpit of injection arm; headache; chills; fatigue; This is a spontaneous report from a contactable nurse (patient). A 29-year-old female patient received the 2nd dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL3249 and expiry date: unknown), intramuscular left arm on 10Jan2021 09:45 at single dose for COVID-19 immunisation. The patient medical history was not reported. Patient was not pregnant. Concomitant medication included melatonin, ascorbic acid, betacarotene, calcium sulfate, colecalciferol, cyanocobalamin, ferrous fumarate, folic acid, nicotinamide, pyridoxine hydrochloride, retinol acetate, riboflavin, thiamine mononitrate, tocopheryl acetate, zinc oxide (PRENATAL VITAMINS). Patient took the 1st dose (lot number: EL4284) on intramuscular left arm on 23Dec2020 10:15. The patient experienced sore arm, swollen/tender lymph nodes in armpit of injection arm, headache, chills, fatigue on 10Jan2021 19:30. Outcome of the events was recovering. No treatment was given for the events. Patient was not diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. No follow-up attempts are possible. No further information is expected.

Other Meds: ; PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS

Current Illness:

ID: 0962212
Sex: F
Age:
State: GA

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: nasal congestion/ nose is stopped up; Fever; body ache; Headache; Muscle soreness; Chills; tired; This is a spontaneous report from a contactable consumer reporting for herself. A 59-years-old female patient received the second dose of bnt162b2 (BNT162B2; Lot # EL0142) , via an unspecified route of administration on 08Jan2021 11:00 at single dose for Covid-19 immunisation . The patient medical history and concomitant medications were not reported. The first dose of the vaccine was given on an unknown date. The patient experienced chills on 08Jan2021 23:00 with outcome of recovering , fever on 09Jan2021 with outcome of recovered , body ache on 09Jan2021 with outcome of recovering , headache on 09Jan2021 with outcome of recovered , muscle soreness on 09Jan2021 with outcome of recovering , tired on 08Jan2021 with outcome of recovering , nasal congestion/ nose is stopped up on an unspecified date with outcome of recovered. Paracetamol (TYLENOL) was taken as a result of chills.

Other Meds:

Current Illness:

ID: 0962213
Sex: F
Age:
State: FL

Vax Date: 01/08/2021
Onset Date: 01/09/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Name: Height; Result Unstructured Data: Test Result:She is about 5'1"

Allergies:

Symptoms: she thinks she lost an inch; mild headache; tired, feeling wiped out; This is a spontaneous report from a contactable consumer. A 79-years-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3246, expiration date unknown), intramuscular on the left upper arm on 08Jan2021 at 14:15 to 14:30 at a single dose for COVID-19 immunization. Medical history was not reported. There were no concomitant medications, no additional vaccines administered on the same date of BNT162B2 and there were no prior vaccinations within 4 weeks. The patient previously received flu vaccine and experienced a slight reaction to the flu vaccine, she does not recall when she had it. She got it in the supermarket (she was told one vaccine was super and one flu vaccine was regular, and she had the super vaccine and she thinks that is why she had the side effects). She does not know the name of the flu vaccine or have lot number to provide. The patient was calling about the COVID vaccine that she received a couple of days ago. She received the first dose on Friday, 08Jan2021. She wanted to call and report the side effects. She had a mild headache and was tired. She started feeling tired on Saturday, reported that she felt wiped out. It was reported that the events headache and feeling tired both started on Saturday (09Jan2021). It was also reported that she is about 5'1", she thinks she lost an inch, and that her headache is going away - it was not a major headache, not a migraine. She also took Tylenol as treatment. Her tiredness went away about 48 hours later, and confirmed she recovered completely as of that day. She was alarmed at first and she was wondering where the headache was coming from. She read the paperwork she received, and it is listed as a side effect. She was told that there may be some soreness when she went in to get the vaccine. The event tired, feeling wiped out resolved on 11Jan2021 while the mild headache was resolving and the outcome of the event she thinks she lost an inch was unknown.

Other Meds:

Current Illness:

ID: 0962214
Sex: F
Age:
State: IL

Vax Date: 01/06/2021
Onset Date: 01/07/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Fatigue; Extremely swollen lymph nodes in neck on side of injection; Joint pain; This is a spontaneous report from a contactable nurse (reported for self). A 33-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiry date not reported), via an unspecified route of administration on 06Jan2021 15:00 at a single dose in the left arm for Covid-19 immunization. The patient's medical history was not reported. The patient had no Covid prior to vaccination. The patient was not pregnant at the time of vaccination. There were no concomitant medications. The patient had no other vaccine in four weeks and no other medications in two weeks. On 07Jan2021, patient experienced fatigue, extremely swollen lymph nodes in neck on side of injection, and joint pain. The patient did not receive treatment in response to the events reported. The patient was not tested for COVID post vaccination. The events fatigue, extremely swollen lymph nodes in neck on side of injection, and joint pain were reported as not recovered. Information regarding lot/batch number of the product has been requested.

Other Meds:

Current Illness:

ID: 0962215
Sex: F
Age:
State: MO

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Date: 20210110; Test Name: heartbeat; Result Unstructured Data: Test Result:fast

Allergies:

Symptoms: Joint tightness/tightness of her joints and muscles; Muscle tightness/tightness of her joints and muscles; Tiredness/felt tired; fast heartbeat; Difficulty breathing; Dizzy; Nausea; Joint pain; Muscle pain; she was not feeling well; swelling and tightness in her left arm; swelling and tightness in her left arm; Injection site redness/redness of her left arm and injection site swelling; Injection site swelling; This is a spontaneous report received from a contactable other healthcare professional (who is also the patient). A 42-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3248, expiry date unknown), via an unspecified route of administration in upper left arm, on 08Jan2021 09:25, at single dose, for COVID-19 immunization, in a public health department. There were no medical history and concomitant medications. The patient did not receive prior vaccinations within 4 weeks. The patient reported she received the COVID-19 Vaccine on Friday, clarified as 08Jan2021 at 9:25 in her left upper arm. She stated experiencing a little bit of side effects since receiving the COVID-19 Vaccine. Shortly after receiving the COVID-19 Vaccine, on 08Jan2021, she was not feeling well. She said she had swelling and tightness in her left arm that started approximately a half hour (30 mins) after receiving the COVID-19 Vaccine on 08Jan2021. She then experienced redness of her left arm and injection site swelling on 08Jan2021. On 10Jan2021 (at night), she felt tired, and had tightness of her joints and muscles. She also experienced a fast heartbeat, and difficulty breathing last night, 10Jan2021. She said her dizzy feeling, nausea, tiredness, and joint and muscle pain were persisting at the time of the report. She reported she thought she was feeling fine up until Sunday, 10Jan2021. She stated her new symptoms started in the late afternoon, and the symptoms have stayed into the morning of 11Jan2021. She reported having previously scheduled a doctor's appointment for 22Jan2021 and will speak with her doctor at that time if she continues to have symptoms. The patient declined treatment for the events. The outcome of the events are joint stiffness, muscle tightness, fatigue, dizziness, nausea, arthralgia and myalgia was not recovered; peripheral swelling, musculoskeletal stiffness, heart rate increased and dyspnea were recovering; vaccination site erythema and vaccination site swelling were recovered on an unspecified date; and malaise was unknown.

Other Meds:

Current Illness:

ID: 0962216
Sex: M
Age:
State: NY

Vax Date: 12/21/2020
Onset Date: 12/21/2020
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Date: 2020; Test Name: COVID-19 test; Test Result: Positive ; Test Date: 2020; Test Name: COVID-19 test; Test Result: Negative ; Test Date: 2020; Test Name: COVID-19 test; Test Result: Negative ; Test Date: 202012; Test Name: COVID-19 test; Test Result: Negative ; Test Name: TB test; Test Result: Positive

Allergies:

Symptoms: Back pain; Headache; Would be sleeping and would wake up in middle of night; Felt like a sinus headache on one side of the head; Neck pain; Could not lift his arm; his neck he could not turn it; Bruised under the arm; This is a spontaneous report from a contactable consumer (patient). A 40-year-old male patient started to receive the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number and Expiration Date were not reported), via an unspecified route of administration in left arm, on 21Dec2020, at a single dose, for COVID-19 immunization. The patient's medical history human immunodeficiency virus (HIV), COVID-19 in 2020 (Jun2020 or Jul2020; tested positive for COVID-19 at that time and has 3 tests after that which were all negative) and since then lost weight (2020), and root canal. The patient had no issues with vaccines in the past. There were issues with the tuberculosis (TB) vaccine, because he would be positive to TB, but this is because of his culture, he is from a specific country, and so they cannot take that vaccine. The patient clarified that he did not take the TB vaccine, what he meant was he is aware he can't take it. On 21Dec2020, the patient works in healthcare and had a patient that came in that tested positive for COVID-19 and so because of that, everyone including him that came in contact with the COVID-19 positive patient had to check and get tested. This happened the same day as his first dose of COVID-19 vaccine, the test (Dec2020) came out negative. There were no concomitant medications. The patient had not had any antibody test for COVID-19. The patient asked the doctor, but she never scheduled him for that, until after last month, she talked to him about it, but by that time he told her that he doesn't need it now - it's been almost a year. The patient had the first dose on 21Dec2020 and at that time he did experience symptoms the next day (22Dec2020). At that time after the first dose administration (21Dec2020), he could not lift his arm and it was bruised under the arm. The next day (22Dec2020), he had back pain, with his neck he could not turn it (neck pain), he could not be on his left side where he got the shot on left arm, it was like that for 3 days. Then on Thursday (24Dec2020), he had headache every time he bended his head down, he would be sleeping and would wake up in middle of night because of the headache, it felt like a sinus headache on one side of the head, and when he bend his head down, he would feel it, it stayed this way till 29Dec2020 (Tuesday). The patient has a question trying to find out with his employer. They told them they need to take the vaccine, they pushed them to take the vaccine, he works in healthcare. If they get sick at the job, he asked if they (employer) would pay for it, how would he get paid. The job told him he gets paid sick days and asked how they would do that. The patient asked how long the vaccine was alive in the body and how does it work. The outcome of the events was unknown. Information about lot number and expiration date for the suspect product will be requested in follow-up attempts.

Other Meds:

Current Illness: Exposure to COVID-19

ID: 0962217
Sex: F
Age:
State: CA

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Severe headache; chills; body pain; intermittent nausea; extreme fatigue; brain fog; arm pain at injection site; This is a spontaneous report from a non-contactable nurse (patient). A 48-year-old non-pregnant female patient received her second dose of bnt162b2 (BNT162B2 reported as Pfizer BioNTech COVID VACCINE; lot number: EL3249; expiration date: unknown), via an unspecified route of administration left arm on 08Jan2021 16:00 at a single dose for covid-19 immunization. Medical history included asthma, pain and allergies to sulfa drugs. Concomitant medication included montelukast sodium (SINGULAIR), estradiol, meloxicam and fexofenadine (FEXOFENADINE). The patient received her first dose of bnt162b2 (BNT162B2 reported as Pfizer BioNTech COVID VACCINE; lot number: EJ1685) via an unspecified route of administration left arm on 19Dec2020 04:45 PM at a single dose for covid-19 immunization. The patient has not received other vaccines in four weeks. The received her vaccine in a hospital. On 08Jan2021 5:30 PM, the patient experienced severe headache chills, body pain, intermittent nausea, extreme fatigue, brain fog and arm pain at injection site. No treatment was received from the adverse events. The patient was not diagnosed with Covid prior to vaccination and has not been tested for Covid post vaccination. The outcome of the events was recovering. No follow-up attempts are possible. No further information is expected.

Other Meds: ; SINGULAIR; ;

Current Illness:

ID: 0962218
Sex: M
Age:
State: PA

Vax Date:
Onset Date:
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Fever; Chills; Joint pain; Strange dreams; This is a spontaneous report from a contactable consumer (patient). A male patient of an unspecified age received his first dose of bnt162b2 (BNT162B2 reported as Pfizer COVID vaccine and as Coronavirus Vaccine; unknown lot number and expiration date), via an unspecified route of administration on an unspecified date at a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The reporter stated that he has a student who verbally informed that he was unable to attend class on 19Jan2021 because of his concern of the adverse events from the first vaccine. It was reported that he should take second dose on or around 19Jan2021. The patient experienced fever, chills, joint pain and strange dreams on an unspecified date. He does not have any other information except the list of adverse events that he is experiencing. The outcome of the events was unknown. The following information on the batch/lot number has been requested.

Other Meds:

Current Illness:

ID: 0962219
Sex: M
Age:
State:

Vax Date: 01/10/2021
Onset Date: 01/10/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Headache/ He can't get rid of the headache and he has taken all sorts of Tylenol; This is a spontaneous report from a contactable consumer. This consumer reported similar event for 2 patients. This is the first of 2 reports. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date not reported), via an unspecified route of administration on 10Jan2021 at single dose for COVID-19 immunization. Medical history included allergy to penicillin. The patient's concomitant medications were not reported. The patient took the Pfizer COVID at (Hospital name) on 10Jan2021 and experienced a headache and has been taking Tylenol since yesterday. It was so bad that he went to sleep at 7 and he was still in bed. The patient can't get rid of the headache and he has taken all sorts of Tylenol. The outcome of the event was not recovered. Information on the Lot/Batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021026399 same reporter/drug/event, different patient

Other Meds:

Current Illness:

ID: 0962220
Sex: F
Age:
State:

Vax Date: 01/10/2021
Onset Date: 01/10/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Headache; This is a spontaneous report from a contactable consumer. This consumer reported similar events for two patients. This is the second of two reports. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date not reported), via an unspecified route of administration on 10Jan2021 at a single dose for COVID-19 immunization. The patient's medical history concomitant medications were not reported. The patient took the Pfizer COVID at (Hospital name) on 10Jan2021 and experienced a headache immediately and that went away. The outcome of the event was recovered on 10Jan2021. Information on the Batch/Lot number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021026386 same reporter/drug/event, different patient.

Other Meds:

Current Illness:

ID: 0962221
Sex: F
Age:
State: CT

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Bot fatigue and nasal/sinus congestion 2 days post-inoculation; Bot fatigue and nasal/sinus congestion 2 days post-inoculation; Soreness at injection site; This is a spontaneous report from a non-contactable consumer. A 61-year-old female patient received their second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date not reported), via an unspecified route of administration on the left arm on 08Jan2021 at single dose for COVID-19 immunization. Medical history included allergies: shellfish allergy from an unknown date and unknown if ongoing. Concomitant medication included spironolactone (ALDACTONE), dextrin (BENEFIBER), folic acid, atorvastatin (LIPITOR), famotidine (PEPCID), bifidobacterium bifidum, bifidobacterium lactis, bifidobacterium longum, lactobacillus acidophilus, lactobacillus rhamnosus (PROBIOTIC), estradiol (VIVELLE). The patient received their first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date not reported) via an unspecified route of administration on the left arm on 19Dec2020 for COVID-19 immunization. The patient experienced soreness at injection site on 08Jan2021, bot fatigue and nasal/sinus congestion 2 days post-inoculation on 10Jan2021. The patient was recovering from the events. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds: ALDACTONE [SPIRONOLACTONE]; BENEFIBER [DEXTRIN]; ; LIPITOR [ATORVASTATIN]; PEPCID [FAMOTIDINE]; PROBIOTIC [BIFIDOBACTERIUM BIFIDUM;BIFIDOBACTERIUM LACTIS;BIFIDOBACTERIUM LONGUM;LACTOBACILLUS ACIDO; VIVELLE [ESTRADIOL]

Current Illness:

ID: 0962222
Sex: F
Age:
State:

Vax Date: 12/18/2020
Onset Date: 01/06/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Date: 20210107; Test Name: hearing test; Result Unstructured Data: Test Result:20% hearing loss; Test Date: 20210107; Test Name: Audiogram; Result Unstructured Data: Test Result:20% hearing loss; Test Date: 202101; Test Name: COVID test; Test Result: Negative

Allergies:

Symptoms: Hearing loss; This is a spontaneous report from a contactable Nurse Anesthetist (patient). A 39-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Batch/lot number: EL0140) on 18Dec2020 at single dose in the left deltoid for COVID-19 immunization.Medical history included ongoing anaemia. There were no concomitant medications. On 06Jan2021 at 16:00 the patient experienced hearing loss, serious as medically significant. Patient had no problems with her ears before hand. On 06Jan2021 around 4 PM, she was just walking in the store, with no loud music or anything, and all of a sudden her hearing in her left ear went lost and muffled. On 07Jan2021 she went to the Otolaryngologist (ENT doctor) to get her ears checked. They said no it looked perfectly fine. They did an audiogram and hearing test on 07Jan2021 and there was a 20% hearing loss. She had no idea what it was from. She took no other medications. She had anemia but that was it. She was wondering if hearing loss has been reported with the vaccine either in the studies or recently. She researched it, and with the COVID virus itself, back in Jul2020 and Oct2020, people reported hearing loss. So she went and had a COVID test in Jan2021 and it was negative. Patient stated it was very scary and weird. Event treatment included high dose oral steroids to see if it can be treated and the ENT doctor was also giving her steroid shots in the ear. She was due to see him again in Jan2021. The outcome of the event Hearing loss was not recovered. Patient also clarified that she did continue with her second dose of the vaccine on 08Jan2021. She had asked the ENT doctor his opinions on still getting the second dose, and he recommended it. The second dose of the vaccine was given on 08Jan2021 (lot EL3302, EXP: May2021) at single dose in the left deltoid for COVID-19 immunization.; Sender's Comments: A possible contributory effect of suspect BNT162B2 on reported hearing loss cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.

Other Meds:

Current Illness: Anaemia

Total 2021 VAERS Injuries: 134,999

Page last modified: 14 December 2021 10:42pm